http://www.nephrologynow.com/publications/effects-of-valsartan-on-morbidity-and-mortality-in-uncontrolled-hypertensive-patients-with-high-cardiovascular-risks-kyoto-heart-study Tue, 24 Aug 2010 16:29:14 +0000 hourly 1 http://wordpress.org/?v=3.0.1 http://www.nephrologynow.com/publications/effects-of-valsartan-on-morbidity-and-mortality-in-uncontrolled-hypertensive-patients-with-high-cardiovascular-risks-kyoto-heart-study/comment-page-1#comment-129 Giancarlo Ruggieri Wed, 28 Oct 2009 15:17:22 +0000 http://www.nephrologynow.com/?p=1193#comment-129 My first concern is according to that of R Jenkins. The second one is the lack of explicantions about the different incidence of brain vascular events of Japanese people versus the others populations, difference on which could possibly be based the best efficacy of ARBS My first concern is according to that of R Jenkins. The second one is the lack of explicantions about the different incidence of brain vascular events of Japanese people versus the others populations, difference on which could possibly be based the best efficacy of ARBS

]]> http://www.nephrologynow.com/publications/effects-of-valsartan-on-morbidity-and-mortality-in-uncontrolled-hypertensive-patients-with-high-cardiovascular-risks-kyoto-heart-study/comment-page-1#comment-125 R Jenkins Sun, 25 Oct 2009 01:46:43 +0000 http://www.nephrologynow.com/?p=1193#comment-125 An interesting paper which supports the use of ARBs to reduce hard clinical endpoints. My only concern is whether the results of this paper can be generalized beyond Japanese patients. An interesting paper which supports the use of ARBs to reduce hard clinical endpoints. My only concern is whether the results of this paper can be generalized beyond Japanese patients.

]]>